But in
advocating for the drug, sold under the brand name Truvada, officials seeking to curtail HIV /
AIDS infections are going up against some surprising opponents: high - profile
AIDS activists who say they have serious
questions about the drug's cultural and health impacts.
The meeting took place against the backdrop of the uproar concerning further cuts to the legal
aid fees paid to practitioners following the recent additions to the
Advocates» Graduated Fee Scheme («AGFS»), a matter which naturally made its way into the conversation through constructive
questions and statements.